Rhythm Pharmaceuticals, Inc. (RYTM)
104.78
+4.07
(+4.04%)
USD |
NASDAQ |
Dec 10, 16:00
109.21
+4.43
(+4.23%)
After-Hours: 19:55
Rhythm Pharmaceuticals Market Cap: 6.993B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 150.58B |
| Terns Pharmaceuticals, Inc. | 4.014B |
| Altimmune, Inc. | 566.06M |
| Viking Therapeutics, Inc. | 4.242B |
| Cidara Therapeutics, Inc. | 6.910B |
Market Cap Related Metrics
| PS Ratio | 38.26 |
| Price to Book Value | 46.99 |
| Price | 104.78 |
| Earnings Yield | -2.96% |